{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:27:43Z","timestamp":1771946863511,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jsat.2015.05.004","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T02:32:32Z","timestamp":1431484352000},"page":"102-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A Retrospective Evaluation of Inpatient Transfer from High-Dose Methadone to Buprenorphine Substitution Therapy"],"prefix":"10.1016","volume":"57","author":[{"given":"Rossana","family":"Oretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2015.05.004_bb0005","series-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHSS publication no. (SMA) 04-3939","author":"Center for Substance Abuse Treatment","year":"2004"},{"key":"10.1016\/j.jsat.2015.05.004_bb0010","first-page":"19","article-title":"Transfer to buprenorphine from daily doses of methadone greater than 30mg\u2014Initial review of transfers","volume":"15","author":"Conroy","year":"2013","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"10.1016\/j.jsat.2015.05.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207458","article-title":"Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use\u2014Buprenorphine\/naloxone treatment and recovery in a surgical patient","author":"Conroy","year":"2014","journal-title":"BMJ. Case Reports"},{"key":"10.1016\/j.jsat.2015.05.004_bb0020","series-title":"Drug misuse and dependence: UK Guidelines on Clinical Management","author":"Department of Health (England)","year":"2007"},{"key":"10.1016\/j.jsat.2015.05.004_bb0025","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1360-0443.1999.94913376.x","article-title":"Buprenorphine versus methadone maintenance for the treatment of opioid dependence","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2015.05.004_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/13556210500123126","article-title":"Induction of patients with moderately severe methadone dependence onto buprenorphine","volume":"10","author":"Glasper","year":"2005","journal-title":"Addiction Biology"},{"key":"10.1016\/j.jsat.2015.05.004_bb0035","series-title":"National guidelines for medication-assisted treatment of opioid dependence","author":"Gowing","year":"2014"},{"key":"10.1016\/j.jsat.2015.05.004_bb0040","series-title":"National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence","author":"Lintzeris","year":"2006"},{"key":"10.1016\/j.jsat.2015.05.004_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsat.2012.04.003","article-title":"Medically assisted recovery from opiate dependence within the context of the UK drug strategy: Methadone and Suboxone (buprenorphine\u2013naloxone) patients compared","volume":"44","author":"McKeganey","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2015.05.004_bb0050","series-title":"Methadone and buprenorphine for the management of opioid dependence. TA114","author":"National Institute for Health and Care Excellence","year":"2007"},{"key":"10.1016\/j.jsat.2015.05.004_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2007.04.006","article-title":"Sublingual buprenorphine\/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone","volume":"90","author":"Rosado","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2015.05.004_bb0060","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2015.05.004_bb0065","first-page":"42","article-title":"Transfer from high dose methadone to buprenorphine\/naloxone","volume":"19","author":"Wallace","year":"2011","journal-title":"Australian Nursing Journal"},{"key":"10.1016\/j.jsat.2015.05.004_bb0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"Journal of Psychoactive Drugs"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547215001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547215001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:42:30Z","timestamp":1760038950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547215001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":14,"alternative-id":["S0740547215001129"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2015.05.004","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Retrospective Evaluation of Inpatient Transfer from High-Dose Methadone to Buprenorphine Substitution Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2015.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}